At the time of menopause, most women experience a group of symptoms composed of vague somatic complaints, such as hot flushes, sweats, chilly sensation, numbness, general malaise, dull headache, etc., without any identifiable objective signs accountable for the symptoms. Etiology of these symptoms has been reported to be implicated in low output of ovarian estrogen and high production of pituitary gonadotrophin (Ferriman and Purdie 1965; Jeffcoate 1967 ; Aitken et al. 1974) , and based on this implication, estrogenic preparations are explained to be effective on the symptoms.
Neurotics in menopausal women, who are connected with psychotic origin rather than endocrine one, complain of similar symptoms. The hormonal treatment is effective only for the non-neurotics. Therefore, differential diagnosis between neurotics and non-neurotics is necessary for the treatment of climacteric women with menopausal symptoms.
In an attempt to differentiate the non-neurotics from the neurotics, we administered conjugated estrogen to climacteric women complaining of the menopausal symptoms and evaluated the differences in their reactions.
PATIENTS AND METHODS
A total of 64 women aged 35 to 69 years who complained of the menopausal symptoms but showed no signs of either gynecological or any other somatic disorders at the moment and in the past time were subjected for this study.
They were requested to fill a questionnaire concerning various symptoms, and their Kupperman's menopausal indices (Kupperman et al. 1959 ; Abe et al. 1975 ) were calculated. Then, the patients were given an intravenous injection of 20 mg of conjugated estrogen (Premarin) and the menopausal indices were calculated again on the thrid or the fourth day after injection. Subsequently, they were entrusted to psychiatrists to determine the presence or absence of neurotic abnormality.
They were divided into two groups, one with and the other without neurotic abnormality, according to the diagnosis by the psychiatrists.
A comparison was made between the two groups with respect to the effect of conjugated estrogen on the menopausal index. According to this formula, a discriminant line was drawn in Fig. 1 . When a dot is located in the lower area below this line it is classified into the non-neurotic group ;
RESULTS
and when located in the upper area over the line, it is classified into the neurotic group.
This calculative screening was consistent with the clinical diagnosis in about 94% of the cases of the neurotic group and about 87% of the cases of the non neurotic group, as shown in Table 2 . function and that these symptoms are due to a generalized hypothalamo hypophysial disorder including raised gonadotrophin production and excretion (Aitken et al. 1974 ). Many reports have proposed that the administration of estrogen would relieve the symptoms by its inhibition or stimulation of pituitary gonadotrophin (Jasani et al. 1965 ).
The neurotics of the climacteric women also complain of similar symptoms. But these patients show different reaction to estrogen administration as compared with the non-neurotics, and hence the intravenous injection of estrogen would be of value for screening of the neurotics and the non-neurotics complaining of menopausal symptoms (Abe et al. 1975) .
In this study, estrogen was administered intravenously to the patients with menopausal symptoms and found that the symptoms were relieved in the non neurotics but not altered in the neurotics. The mechanism of this difference in reaction is unknown but the difference was evaluated to be of value for clinical screening of the neurotics and the non-neurotics.
